S&P 500
(0.25%) 5 321.41 points
Dow Jones
(0.17%) 39 873 points
Nasdaq
(0.22%) 16 833 points
Oil
(-0.93%) $79.06
Gas
(-2.47%) $2.68
Gold
(-0.46%) $2 427.40
Silver
(-0.45%) $32.28
Platinum
(0.17%) $1 065.50
USD/EUR
(0.05%) $0.921
USD/NOK
(-0.23%) $10.67
USD/GBP
(-0.03%) $0.787
USD/RUB
(-0.39%) $90.33

Realtime updates for Oncopeptides AB (publ) [ONCO.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated21 May 2024 @ 11:29

1.45% SEK 2.79

Live Chart Being Loaded With Signals

Commentary (21 May 2024 @ 11:29):

Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally...

Stats
Today's Volume 1.20M
Average Volume 1.10M
Market Cap 577.15M
EPS SEK0 ( 2024-05-03 )
Next earnings date ( SEK0 ) 2024-05-30
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -1.420
ATR14 SEK0.0100 (0.36%)

Volume Correlation

Long: 0.08 (neutral)
Short: -0.56 (weak negative)
Signal:(52.886) Neutral

Oncopeptides AB (publ) Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Oncopeptides AB (publ) Correlation - Currency/Commodity

The country flag -0.29
( neutral )
The country flag -0.20
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.60
( weak )
The country flag 0.33
( neutral )

Oncopeptides AB (publ) Financials

Annual 2023
Revenue: SEK35.22M
Gross Profit: SEK36.30M (103.06 %)
EPS: SEK-1.960
FY 2023
Revenue: SEK35.22M
Gross Profit: SEK36.30M (103.06 %)
EPS: SEK-1.960
FY 2022
Revenue: SEK8.36M
Gross Profit: SEK8.35M (99.93 %)
EPS: SEK-4.11
FY 2021
Revenue: SEK118.30M
Gross Profit: SEK65.17M (55.09 %)
EPS: SEK-19.00

Financial Reports:

No articles found.

Oncopeptides AB (publ) Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Oncopeptides AB (publ)

Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally. Its lead product candidate is melflufen, an anti-cancer peptide drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators